# Tune Therapeutics funding rounds and investors

As of 14 Oct 2026, Tune Therapeutics has raised $175M across 1 verified round on record; latest: $175 million Series B led by Hevolution Foundation, New Enterprise Associates and 2 others, announced 13 Jan 2025.

TuneTx sells genetic tuning technology aimed at transforming health through gene and regenerative therapies, targeting diseases at their source.

Website: https://tunetx.com  
Page: https://fireround.dev/companies/tunetx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-01-13 | Series B | $175 million | Hevolution Foundation, New Enterprise Associates, Regeneron Ventures, Yosemite | none named | [fiercebiotech.com](https://www.fiercebiotech.com/biotech/epigenetic-biotech-raises-bumper-round-tune-175m-fund-first-hbv-trials) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.